19:35 , Dec 6, 2016 |  BC Innovations  |  Distillery Therapeutics

Endocrine / Metabolic

INDICATION: Lipodystrophy Mouse and cell culture studies suggest inhibiting GPAT3 and/or GPAT4 could help treat congenital generalized lipodystrophy type 2, which is caused by mutations in BSCL2 . In a mouse model of the disease,...
08:00 , Feb 21, 2008 |  BC Innovations  |  Distillery Therapeutics

This Week in Therapeutics

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Endocrine disease Lipodystrophy Seipin; few lipid droplets (FLD) Studies in yeast suggest that targeting seipin in humans might help reverse some forms...